Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma. Boudy AS, Grausz N, Selleret L, Gligorov J, et al. Lung Cancer 2021;161:68-75.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boudy AS, Grausz N, Selleret L, Gligorov J, et al. Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma. Lung Cancer 2021;161:68-75.
PMID: 34543940